Medicinal Products

Dáil Éireann Debate, Tuesday - 3 March 2026

• Díospóireachtaí
• Aimsigh díospóireacht
  • Díospóireachtaí na Dála
  • Díospóireachtaí an tSeanaid
  • Díospóireachtaí Coiste
• Aimsigh vótáil
  • Vótálacha na Dála
  • Vótálacha an tSeanaid
  • Vótálacha Coiste
• Ceisteanna Parlaiminte
  • Ceisteanna scríofa
  • Ceisteanna ó bhéal
• Leideanna cuardaigh
• Nuair a bhíonn tionchar tromchúiseach ag aithrisí

Tuesday, 3 March 2026

Ceisteanna (875)

Paul McAuliffe

Ceist:

875. Deputy Paul McAuliffe asked the Minister for Health if she will consider the inclusion of plenadren, a life-saving medication for adrenal insufficiency, under the HSE hardship fund; if she will consider the appeal case of a person (details supplied); and if she will make a statement on the matter. [16674/26]

Freagraí scríofa

Minister for Health

As this is a service matter and under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines and medical devices, this question has been referred to the HSE for attention and direct reply to the Deputy.

Question No. 876 answered with Question No. 812.

• An Freagra Roimhe Sin
• An Chéad Fhreagra eile